SI2099489T1 - Sestavki in postopki za zdravljenje neoplazme - Google Patents
Sestavki in postopki za zdravljenje neoplazmeInfo
- Publication number
- SI2099489T1 SI2099489T1 SI200731500T SI200731500T SI2099489T1 SI 2099489 T1 SI2099489 T1 SI 2099489T1 SI 200731500 T SI200731500 T SI 200731500T SI 200731500 T SI200731500 T SI 200731500T SI 2099489 T1 SI2099489 T1 SI 2099489T1
- Authority
- SI
- Slovenia
- Prior art keywords
- neoplasm
- compositions
- treating
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87446006P | 2006-12-11 | 2006-12-11 | |
PCT/US2007/068300 WO2008073509A2 (en) | 2006-12-11 | 2007-05-04 | Compositions and methods for treating a neoplasm |
EP07761925.2A EP2099489B1 (en) | 2006-12-11 | 2007-05-04 | Compositions and methods for treating a neoplasm |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2099489T1 true SI2099489T1 (sl) | 2014-09-30 |
Family
ID=38521756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200731500T SI2099489T1 (sl) | 2006-12-11 | 2007-05-04 | Sestavki in postopki za zdravljenje neoplazme |
Country Status (18)
Country | Link |
---|---|
US (1) | US20100086544A1 (sl) |
EP (1) | EP2099489B1 (sl) |
JP (1) | JP2010512407A (sl) |
KR (1) | KR101320198B1 (sl) |
CN (1) | CN101547705B (sl) |
AU (1) | AU2007333565A1 (sl) |
BR (1) | BRPI0717688A2 (sl) |
CA (1) | CA2670707A1 (sl) |
DK (1) | DK2099489T3 (sl) |
HK (1) | HK1131064A1 (sl) |
IL (1) | IL198852A (sl) |
MX (1) | MX2009006202A (sl) |
NZ (1) | NZ577058A (sl) |
RU (1) | RU2482877C2 (sl) |
SG (1) | SG177891A1 (sl) |
SI (1) | SI2099489T1 (sl) |
WO (1) | WO2008073509A2 (sl) |
ZA (1) | ZA200903489B (sl) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2066694T3 (pl) * | 2006-09-29 | 2016-04-29 | Oncomed Pharm Inc | Kompozycje i sposoby diagnozowania i leczenia nowotworu |
PL3072526T3 (pl) | 2009-10-16 | 2019-04-30 | Oncomed Pharm Inc | Kombinacja terapeutyczna i zastosowanie przeciwciał antagonistycznych względem DLL4 i środków antyhipertensyjnych |
US8551479B2 (en) | 2010-09-10 | 2013-10-08 | Oncomed Pharmaceuticals, Inc. | Methods for treating melanoma |
US8987271B2 (en) | 2010-12-22 | 2015-03-24 | Eutropics Pharmaceuticals, Inc. | 2,2′-biphenazine compounds and methods useful for treating disease |
LT3485903T (lt) | 2011-09-23 | 2023-02-27 | Mereo Biopharma 5, Inc. | Vegf/ dll4 surišantys agentai ir jų panaudojimas |
US9315481B2 (en) * | 2012-03-14 | 2016-04-19 | Indiana University Research And Technology Corporation | Compounds and methods for treating leukemia |
US9599620B2 (en) | 2012-10-31 | 2017-03-21 | Oncomed Pharmaceuticals, Inc. | Methods and monitoring of treatment with a DLL4 antagonist |
GB201409471D0 (en) * | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
AU2015338974B2 (en) | 2014-10-31 | 2021-08-26 | Oncomed Pharmaceuticals, Inc. | Combination therapy for treatment of disease |
EP3328844B1 (en) | 2015-07-27 | 2019-11-27 | Chong Kun Dang Pharmaceutical Corp. | 1,3,4-oxadiazole sulfamide derivatives as histone deacetylase 6 inhibitor and pharmaceutical composition comprising the same |
MY197262A (en) | 2015-07-27 | 2023-06-08 | Chong Kun Dang Pharmaceutical Corp | 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same |
PL3330259T3 (pl) | 2015-07-27 | 2021-02-08 | Chong Kun Dang Pharmaceutical Corp. | Związek pochodna amidowa 1,3,4-oksadiazolu jako inhibitor deacetylazy histonowej 6 i kompozycja farmaceutyczna go zawierająca |
MY197738A (en) | 2015-08-04 | 2023-07-12 | Chong Kun Dang Pharmaceutical Corp | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same |
EP3353204B1 (en) | 2015-09-23 | 2023-10-18 | Mereo BioPharma 5, Inc. | Bi-specific anti-vegf/dll4 antibody for use in treating platinum-resistant ovarian cancer |
NZ740809A (en) | 2015-10-12 | 2019-04-26 | Chong Kun Dang Pharmaceutical Corp | Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same |
SG11202007130RA (en) | 2018-01-26 | 2020-08-28 | Univ California | Methods and compositions for treatment of angiogenic disorders using anti-vegf agents |
KR102316234B1 (ko) | 2018-07-26 | 2021-10-22 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
WO2021108255A1 (en) | 2019-11-25 | 2021-06-03 | The Regents Of The University Of California | Long-acting vegf inhibitors for intraocular neovascularization |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6281230B1 (en) * | 1996-07-24 | 2001-08-28 | Celgene Corporation | Isoindolines, method of use, and pharmaceutical compositions |
US5635517B1 (en) * | 1996-07-24 | 1999-06-29 | Celgene Corp | Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines |
SE9704545D0 (sv) * | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
US6169106B1 (en) * | 1998-04-15 | 2001-01-02 | Boehringer Ingelheim Pharma Kg | Indolinones having kinase inhibitory activity |
YU21301A (sh) * | 1998-09-25 | 2003-04-30 | Boehringer Ingelheim Pharama Gmbh. & Co. Kg. | Novi supstituisani indolinoni sa inhibitorskim efektom za različite kinaze i komplekse ciklin/cdk |
US6762180B1 (en) * | 1999-10-13 | 2004-07-13 | Boehringer Ingelheim Pharma Kg | Substituted indolines which inhibit receptor tyrosine kinases |
US6638965B2 (en) * | 2000-11-01 | 2003-10-28 | Boehringer Ingelheim Pharma Kg | Substituted indolinones, preparation thereof and their use as pharmaceutical compositions |
US7323479B2 (en) * | 2002-05-17 | 2008-01-29 | Celgene Corporation | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
US20050106667A1 (en) | 2003-08-01 | 2005-05-19 | Genentech, Inc | Binding polypeptides with restricted diversity sequences |
US7758859B2 (en) * | 2003-08-01 | 2010-07-20 | Genentech, Inc. | Anti-VEGF antibodies |
AR069501A1 (es) * | 2007-11-30 | 2010-01-27 | Genentech Inc | Anticuerpos anti- vegf (factor de crecimiento endotelial vascular) |
-
2007
- 2007-05-04 MX MX2009006202A patent/MX2009006202A/es active IP Right Grant
- 2007-05-04 AU AU2007333565A patent/AU2007333565A1/en not_active Abandoned
- 2007-05-04 SI SI200731500T patent/SI2099489T1/sl unknown
- 2007-05-04 ZA ZA200903489A patent/ZA200903489B/xx unknown
- 2007-05-04 US US12/518,628 patent/US20100086544A1/en not_active Abandoned
- 2007-05-04 CA CA002670707A patent/CA2670707A1/en not_active Abandoned
- 2007-05-04 NZ NZ577058A patent/NZ577058A/en not_active IP Right Cessation
- 2007-05-04 DK DK07761925.2T patent/DK2099489T3/da active
- 2007-05-04 RU RU2009126588/15A patent/RU2482877C2/ru not_active IP Right Cessation
- 2007-05-04 BR BRPI0717688-0A patent/BRPI0717688A2/pt not_active IP Right Cessation
- 2007-05-04 EP EP07761925.2A patent/EP2099489B1/en active Active
- 2007-05-04 KR KR1020097011980A patent/KR101320198B1/ko active IP Right Grant
- 2007-05-04 WO PCT/US2007/068300 patent/WO2008073509A2/en active Application Filing
- 2007-05-04 JP JP2009541425A patent/JP2010512407A/ja active Pending
- 2007-05-04 CN CN2007800451061A patent/CN101547705B/zh not_active Expired - Fee Related
- 2007-05-04 SG SG2011091626A patent/SG177891A1/en unknown
-
2009
- 2009-05-20 IL IL198852A patent/IL198852A/en active IP Right Grant
- 2009-11-20 HK HK09110894.7A patent/HK1131064A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2008073509A2 (en) | 2008-06-19 |
IL198852A0 (en) | 2011-08-01 |
HK1131064A1 (en) | 2010-01-15 |
BRPI0717688A2 (pt) | 2013-01-22 |
NZ577058A (en) | 2012-04-27 |
KR101320198B1 (ko) | 2013-10-30 |
CN101547705A (zh) | 2009-09-30 |
MX2009006202A (es) | 2009-06-22 |
RU2009126588A (ru) | 2011-01-20 |
ZA200903489B (en) | 2010-08-25 |
AU2007333565A1 (en) | 2008-06-19 |
WO2008073509A3 (en) | 2009-01-08 |
SG177891A1 (en) | 2012-02-28 |
EP2099489A2 (en) | 2009-09-16 |
CA2670707A1 (en) | 2008-06-19 |
RU2482877C2 (ru) | 2013-05-27 |
EP2099489B1 (en) | 2014-05-21 |
CN101547705B (zh) | 2013-06-12 |
KR20090087908A (ko) | 2009-08-18 |
IL198852A (en) | 2013-06-27 |
US20100086544A1 (en) | 2010-04-08 |
JP2010512407A (ja) | 2010-04-22 |
DK2099489T3 (da) | 2014-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL198852A0 (en) | Compositions and methods for treating a neoplasm | |
IL257681A (en) | Methods and compositions for the treatment of cancer | |
EP2010117A4 (en) | COMPOSITIONS AND METHODS FOR ADHESION INHIBITION | |
IL195619A0 (en) | Compositions and methods for joininig non-conjoined iumens | |
IL193014A0 (en) | Methods and compositions for treating schizophrenia | |
ZA200902860B (en) | Compositions and methods for binding sphingosine-1-phosphate | |
HK1137670A1 (en) | Compositions and methods for arthrodetic procedures | |
EP2037929A4 (en) | COMPOSITIONS AND METHODS FOR REDUCING HYPERLIPIDEMIA | |
ZA200900140B (en) | Methods and compositions for treating biofilms | |
EP2101731A4 (en) | PROCESSES AND COMPOSITIONS WITH END OXIFES | |
IL198310A0 (en) | Compositions and method for hair loss prevention | |
EP2015765A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS | |
IL210097A0 (en) | Compositions and methods for treating unfluenza | |
EP2078522A4 (en) | COMPOSITION FOR THE TREATMENT OF ALLERGIES | |
EP2088865A4 (en) | METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS | |
EP2057179A4 (en) | COMPOSITION AND METHOD FOR THE TREATMENT OF MYELOSUPPRESSION | |
EP2016706A4 (en) | METHOD AND ARRANGEMENT FOR VIRTUAL MEETING | |
EP2132251A4 (en) | COMPOSITION AND METHOD | |
GB0625208D0 (en) | Composition and method | |
GB0600261D0 (en) | Composition and method | |
EP2094279A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA | |
EP2170314A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PHENYLCETONURIA | |
GB0607488D0 (en) | Composition and process | |
GB0605004D0 (en) | Composition and process | |
GB0604315D0 (en) | Composition and method |